News Releases

• 26 August 2008Pramipexole clinical trial programme in Restless Legs Syndrome (RLS) reveals new significant results
• 17 April 2008New data confirm pramipexole (Mirapexin®/Sifrol®) can significantly reduce sleep disturbance for people with Restless Legs Syndrome (RLS)
• 08 June 2007Efficacy of Boehringer Ingelheim's pramipexole (Mirapexin®/Sifrol®) also demonstrated in patients with daytime RLS symptoms
• news release archive

Documents

• Restless Legs Syndrome Information Sheet - Aug. 2008 - PDF (149 KB)
• Pramipexole Information Sheet - Aug. 2008 - PDF (129 KB)

RLS Book of Bedtime Stories

• 
• Read the book

Educational website on RLS

• 
• Under the Covers of RLS

Related Links

• Media event: Madrid, Spain 2008: The Reality of Restless Legs Syndrome
• Focus on Clincal Research - interactive animation
• Research & Development

External Links

• Boehringer Ingelheim Global Clinical Trials website